EP0811059A4 - Chemokine humaine beta-11 et chemokine humaine alpha-1 - Google Patents

Chemokine humaine beta-11 et chemokine humaine alpha-1

Info

Publication number
EP0811059A4
EP0811059A4 EP95911695A EP95911695A EP0811059A4 EP 0811059 A4 EP0811059 A4 EP 0811059A4 EP 95911695 A EP95911695 A EP 95911695A EP 95911695 A EP95911695 A EP 95911695A EP 0811059 A4 EP0811059 A4 EP 0811059A4
Authority
EP
European Patent Office
Prior art keywords
human chemokine
beta
alpha
chemokine
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95911695A
Other languages
German (de)
English (en)
Other versions
EP0811059A1 (fr
Inventor
Haodong Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP0811059A1 publication Critical patent/EP0811059A1/fr
Publication of EP0811059A4 publication Critical patent/EP0811059A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP95911695A 1995-02-08 1995-02-08 Chemokine humaine beta-11 et chemokine humaine alpha-1 Withdrawn EP0811059A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/001780 WO1996024668A1 (fr) 1995-02-08 1995-02-08 Chemokine humaine beta-11 et chemokine humaine alpha-1

Publications (2)

Publication Number Publication Date
EP0811059A1 EP0811059A1 (fr) 1997-12-10
EP0811059A4 true EP0811059A4 (fr) 1998-04-01

Family

ID=22248655

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95911695A Withdrawn EP0811059A4 (fr) 1995-02-08 1995-02-08 Chemokine humaine beta-11 et chemokine humaine alpha-1

Country Status (4)

Country Link
EP (1) EP0811059A4 (fr)
JP (1) JPH10513355A (fr)
AU (1) AU1916795A (fr)
WO (1) WO1996024668A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633149A (en) * 1994-12-07 1997-05-27 Incyte Pharmaceuticals, Inc. Polynucleotide encoding novel chemokine expressed in inflamed adenoid
US6139832A (en) * 1995-02-08 2000-10-31 Human Genome Sciences, Inc. Leukocyte adhesion inhibitor-1 (LAI-1) Polypeptides
CN1190991A (zh) * 1995-06-05 1998-08-19 人类基因组科学公司 人类趋化因子β－11和人类趋化因子α－1
US6410268B1 (en) 1996-03-18 2002-06-25 Human Genome Sciences, Inc. Polynucleotides encoding chemokine alpha-3
NZ332318A (en) * 1996-03-19 2000-10-27 Human Genome Sciences Inc Chemokine alpha 2 and it's therapeutic and diagnostic use in treating illnesses
US5981231A (en) 1996-06-17 1999-11-09 Human Genome Sciences, Inc. Polynucleotides encoding chemokine β-15
JP2000514295A (ja) * 1996-07-05 2000-10-31 シェーリング コーポレイション 哺乳動物のケモカイン試薬
US6723520B2 (en) 1996-07-05 2004-04-20 Schering Corporation Antibodies that bind chemokine teck
AU4243097A (en) * 1996-09-10 1998-04-02 Schering Corporation Mammalian chemokines, related reagents
WO1998011138A1 (fr) * 1996-09-12 1998-03-19 Human Genome Sciences, Inc. Chimiokine alpha-4
US6576445B1 (en) 1996-09-12 2003-06-10 Human Genome Sciences, Inc. Chemokine α-4
CA2267131A1 (fr) * 1996-10-04 1998-04-09 Human Genome Sciences, Inc. Compositions et procedes therapeutiques de traitement d'etats pathologiques par inhibiteur d'adhesion leucocytaire-1 (lai-1) et par chemokine beta-11 (ck.beta.-11)
AU5410698A (en) * 1996-12-13 1998-07-03 Shionogi & Co., Ltd. Human cc chemokine elc
EP1047775A1 (fr) * 1997-01-16 2000-11-02 Human Genome Sciences Facteur de signalisation hematopoietique
US6110695A (en) * 1997-12-02 2000-08-29 The Regents Of The University Of California Modulating the interaction of the chemokine, B Lymphocyte Hemoattractant, and its Receptor, BLR1
US20080199481A1 (en) 2007-02-21 2008-08-21 Astrazeneca Ab Compounds
JP5996429B2 (ja) 2009-09-03 2016-09-21 ジェネンテック， インコーポレイテッド 関節リウマチの治療、診断及びモニターするための方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996017868A1 (fr) * 1994-12-07 1996-06-13 Incyte Pharmaceuticals, Inc. Nouvelle chimiokine exprimee dans un adenoïde enflamme, sa production et ses utilisations
WO1996022374A1 (fr) * 1995-01-19 1996-07-25 Incyte Pharmaceuticals, Inc. Nouvelle chemoquine exprimee dans la rate de foetus, son mode de production et ses utilisations
US6139832A (en) * 1995-02-08 2000-10-31 Human Genome Sciences, Inc. Leukocyte adhesion inhibitor-1 (LAI-1) Polypeptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897348A (en) * 1983-08-25 1990-01-30 Sri International Recombinant materials and methods for producing human connective tissue-activating peptide-III and analogs thereof
US5346686A (en) * 1992-10-05 1994-09-13 Mallinckrodt Medical, Inc. Labelled interleukin-8 and medical uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996017868A1 (fr) * 1994-12-07 1996-06-13 Incyte Pharmaceuticals, Inc. Nouvelle chimiokine exprimee dans un adenoïde enflamme, sa production et ses utilisations
WO1996022374A1 (fr) * 1995-01-19 1996-07-25 Incyte Pharmaceuticals, Inc. Nouvelle chemoquine exprimee dans la rate de foetus, son mode de production et ses utilisations
US6139832A (en) * 1995-02-08 2000-10-31 Human Genome Sciences, Inc. Leukocyte adhesion inhibitor-1 (LAI-1) Polypeptides

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9624668A1 *

Also Published As

Publication number Publication date
EP0811059A1 (fr) 1997-12-10
JPH10513355A (ja) 1998-12-22
AU1916795A (en) 1996-08-27
WO1996024668A1 (fr) 1996-08-15

Similar Documents

Publication Publication Date Title
EP0833914A4 (fr) Chemokine humaine beta-11 et chemokine humaine alpha-1
DE69634852D1 (de) Modulaire stuhlkonstruktion und zusammenbauverfahren
DE69609616D1 (de) Initiatorsystem und daraus hergestellte klebstoffzusammensetzung
IS4481A (is) Díhýdrópyramídín og notkun þeirra
IT1283172B1 (it) Dispositivo di innesto e disinnesto
FI972865L (fi) Hydroksimetyyli-imidatsodiatseptiinejä ja niiden esterit
DE69607979D1 (de) GEBETSZEIT- und -RICHTUNGSBESTIMMUNGSSYSTEM
DK0804078T3 (da) Sammensætning og anvendelse deraf
EP0811059A4 (fr) Chemokine humaine beta-11 et chemokine humaine alpha-1
NO970545D0 (no) Makrofagavledet kjemokin og kjemokinanaloger
BR9506832A (pt) N-pirazolilanilinas e n-pirazolilaminopiridinas
DE69628248D1 (de) Graphenanzeigevorrichtungen und -verfahren
DE69620642D1 (de) Reiningungsverfahren und-zusammensetzung
BR9501946A (pt) Poliuretano-poliuréias hidrófilas e sua aplicação
ID19147A (id) Ksilanase dan pemakaiannya
NO973401D0 (no) Kortikosteroidinneholdende sammensetninger og fremstilling derav
EP0640093A4 (fr) Crabp-i et crabp-ii humaines.
BR9602121A (pt) Poliuretano-poliuréias e sua utilização
FR2739382B1 (fr) Fraction ribosomale et composition la contenant
DE69637548D1 (de) MENSCHLICHE DNAse I VARIANTEN
KR960038005U (ko) 살균 및 조명 겸용등기구
ZA951198B (en) Human chemokine beta-11 and human chemokine alpha-1
KR960033565U (ko) 지압 및 쑥뜸 겸용 지압구
EP0804226A4 (fr) Choline-acetylase humaine
EP0777494A4 (fr) Polypeptides de type chemokine humaine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970908

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20020712

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030602